These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 26%The Indian market, in correction mode for five months, is not a standalone underperformer. A part of the correction does and will continue ...
11 Mar, 2025, 06.10 AM IST
11 Nifty stocks which may outperform the volatile NiftyThis week the Nifty corrected 4%. But did all Nifty stocks correct equally? The answer, obviously, is no. That never happens. If the volati...
06 Oct, 2024, 04.10 PM IST
Cosmo Films to invest Rs 300 crore to set up a new line of speciality polyester filmsIn a regulatory filing, the company said it plans to set up a new line of speciality polyester films (Biaxially-Oriented Polyethylene Terep...
02 Sep, 2020, 12.20 PM IST
Fifteen stocks in focus on Monday, 10 April 2017Religare Enterprises on Sunday announced it will sell its entire 80 per cent stake in Religare Health Insurance
10 Apr, 2017, 08.25 AM IST
2015 in review: Mergers and acquisitions peak in pharma industry; so does regulatory glareThe year also saw the government making an attempt to expand drugs under price control by revising the list of essential medicines.
23 Dec, 2015, 01.08 PM IST
- NGT raps Maharashtra pollution board for failing to act against polluting firms
The green tribunal has taken the state pollution watchdog to task for failing to explain lapses and non-compliance of its directions, espec...
24 Jul, 2015, 06.30 AM IST
Why multibagger Wockhardt is on analysts' 'sell' radar nowFundamental troubles or the regulatory problems are not going to go away in a hurry for Wockhardt and it has become more of a trading stock...
29 Nov, 2013, 05.03 PM IST
Brokerages lower Wockhardt's target price after USFDA import alert on Chikalthana plantThe USFDA import alert on Wockhardt's second plant will have a negative impact on the pharma major, say brokerages.
28 Nov, 2013, 01.07 PM IST
USFDA pulls up Smruthi Organics for norms violation in unitSmruthi Organics today said it has received a notification from the USFDA highlighting violations of manufacturing norms at its Solapur pla...
21 Oct, 2013, 02.49 PM IST
Wockhardt drops 5%, locked in lower circuit as UK health regulator withdraws certificationThe stock is now locked in lower circuit at Rs 499.30. It has lost nearly 10% in the month of October as compared to over 60% fall so far i...
14 Oct, 2013, 09.56 AM IST
UK health regulator withdraws certification of Wockhardt unitThe impact of the same on existing business will only be known once the company receives further communication from UKMHRA, Wockhardt said.
12 Oct, 2013, 05.48 PM IST
Indian drug manufacturing sites face USFDA's warning delugeThe US drug regulator has issued warning letters to Indian drugmakers Promed Exports and Posh Chemicals for violation of good manufacturing...
24 Sep, 2013, 11.28 AM IST
DCGI asks Wockhardt to explain lapses at its plantDrug regulator has sent a letter to Wockhardt, an official said, adding that the deficiencies found by its inspection team did not warrant ...
02 Sep, 2013, 04.30 AM IST
UK regulator MHRA recalls 16 drugs made at Wockhardt's Waluj plantMHRA today said it has issued a precautionary recall for sixteen medicines made by Wockhardt at its Waluj unit due to manufacturing shortco...
12 Jul, 2013, 04.49 AM IST
- We’re enhancing our capacity to 10 bn tablets: Aditi Kare Panandikar, Indoco Remedies
ET Now catches up with Aditi Kare Panandikar, Indoco Remedies Ltd, for her views on the formulation drugmaker’s production network, FDA app...
30 Sep, 2010, 12.38 PM IST